{"id":25,"date":"2013-10-05T14:24:22","date_gmt":"2013-10-05T14:24:22","guid":{"rendered":"http:\/\/www.amuep-agate.de\/cms\/aid\/"},"modified":"2021-01-08T10:25:12","modified_gmt":"2021-01-08T10:25:12","slug":"aid","status":"publish","type":"page","link":"https:\/\/www.amuep-agate.de\/cms\/pharmakoinformation\/aid-start\/aid\/","title":{"rendered":"AIDs"},"content":{"rendered":"

 <\/p>

Stellungnahmen der AGATE<\/span><\/strong><\/span><\/p>

<\/span><\/p>

{attachments}<\/span> <\/p>

2018<\/span><\/strong><\/span><\/p>

AID<\/em><\/span> Gentests<\/em><\/span><\/strong> <\/span>
<\/span><\/strong><\/span><\/p>

[Copyright\u00a9 cand. rer. nat.<\/span>Matthias Sicklinger, Dr. rer. nat. Bianca Fay, Ap. Katharina Endres, Ap. Florian Ridders, Prof. Dr. med. Dr. rer. nat. Ekkehard Haen<\/p>

mit Diskussionbeitr\u00e4gen von Br\u00e4utigam K (Berlin), Hillemacher (N\u00fcrnberg), Hoffmann K (Reichenau), Holter P (Regensburg), Kiefl J (Weiden), Kirchmeier T (Bischofsgr\u00fcn), Knorr R (Reichenau), Ostermeier CP (Werneck), Silva Gracia M (Regensburg), Singer M (Agatharied), Waimer R (N\u00fcrnberg), Wittmann M (W\u00f6llershof)]<\/p>

 <\/p>

2016<\/span><\/span><\/strong><\/span><\/p>

AID Guanfacin: – Vom Blutdrucksenker zum Mittel der Wahl bei ADHS? <\/span><\/strong><\/em><\/p>

[Copyright\u00a9 cand. rer. nat. Julian Sch\u00f6llkopf, Apothekerin Sandra Unholzer, Prof. Dr. med. Dr. rer. nat. Ekkehard Haen]<\/span><\/p>

 <\/p>

AID Trevicta – ein neues intramuskul\u00e4res Dreimonats-Depot-Pr\u00e4parat<\/span>
<\/span><\/strong><\/em><\/p>

[Copyright\u00a9 cand. rer. nat. Teresa Wagner, Apothekerin Bianca Fay, Apothekerin Sandra Unholzer, Prof. Dr. med. Dr. rer. nat. Ekkehard Haen]<\/span><\/p>

 <\/p>

AID Knochenbr\u00fcche durch Opipramol<\/span><\/strong><\/em><\/span><\/p>

[Copyright\u00a9 Nagia BenOmar, Prof. Dr. med. Dr. rer. nat. Ekkehard Haen]<\/span><\/p>

 <\/p>

AID Allesk\u00f6nner Vitamin D<\/strong><\/em> <\/em><\/span><\/span><\/p>

[Copyright\u00a9 Apothekerin Sandra Unholzer, cand. rer. nat. Anika Rothmund, Prof. Dr. med. Dr. rer. nat. Ekkehard Haen]<\/span><\/p>

 <\/p>

AID Abilify\u00ae<\/sup> Maintena\u00ae<\/sup> – ein neues Depotantipsychotikum<\/span><\/strong><\/span><\/em><\/span><\/p>

[Copyright\u00a9 Beatrix Benz, Apothekerin Sandra Unholzer, Apothekerin Alexandra K\u00f6ppl, Prof. Dr. med. Dr. rer. nat. Ekkehard Haen]<\/span><\/p>

Neurotransmitter 2016; 27 (5): 40-44<\/span>
Copyright: \u00a9 Urban & Vogel (2016)<\/span><\/p>

 <\/p>

<\/span><\/p>

 2015<\/span><\/strong><\/span><\/p>

AID Stellenwert von ADSPro<\/em><\/strong><\/span><\/em>\u00ae<\/span><\/strong> bei ADHS<\/em><\/strong><\/span><\/span><\/p>

[Copyright\u00a9 Apothekerin Bianca Fay, Apothekerin Carina Rothammer, Apothekerin Sandra Unholzer, Prof. Dr. med. Dr. rer. nat. Ekkehard Haen]<\/span><\/p>

Neurotransmitter 2016; 27 (4): 26-28<\/span>
Copyright: \u00a9 Urban & Vogel (2016)<\/span><\/p>

 <\/p>

AID Vortioxetin \u2013 ein neues Antidepressivum<\/em><\/strong><\/span><\/p>

[Copyright\u00a9 cand. rer. nat. Sarah Cseh, Ap. Alexandra K\u00f6ppl, Dr. rer. nat. Benedikt Stegmann, Prof. Dr. med. Dr. rer. nat. Ekkehard Haen]<\/span><\/p>

Neurotransmitter 2016; 27 (3): 34-36<\/span>
Copyright: \u00a9 Urban & Vogel (2016)<\/span><\/p>

 <\/p>

AID Lisdexamphetamindimesilat bei ADHS<\/span><\/strong><\/em><\/span><\/p>

[cand. rer. nat. Kristin Rottmann, Apotheker Benedikt Stegmann, Prof. Dr. med. Dr. rer. nat. Ekkehard Haen] <\/span><\/p>

Neurotransmitter 2015; 26 (4): 40-42<\/span>
Copyright: \u00a9 Urban & Vogel (2015) – neurotrans42015.pdf [517 KB]
<\/span><\/strong><\/span><\/p>

<\/span><\/p>

 <\/p>

2013<\/span><\/strong><\/span><\/p>

AID Loxapin \u2013 ein neues Antipsychotikum?
<\/em><\/strong>[cand. rer. nat. Ursula Walter, Dr. med. Katharina Wenzel\u2010Seifert, Prof. Dr. med. Dr. rer. nat Ekkehard Haen]<\/span><\/p>

Neurotransmitter 2016; 27 (2): 29-32<\/span>
Copyright: \u00a9 Urban & Vogel (2016) – neurotrans22016.pdf [464 KB]<\/span><\/span><\/p>

 <\/p>

Tianeptin – Ein neues Antidepressivum?<\/strong><\/em><\/span><\/p>

[cand. rer. nat. Angelika P\u00f6llath, Prof. Dr. med. Dr. rer. nat Ekkehard <\/span>Haen]<\/span><\/p>

Neurotransmitter 2013; 24 (9): 37-38<\/span>
Copyright: \u00a9 Urban & Vogel (2013) – neurotrans92013.pdf [1751 KB]<\/span><\/p>

 <\/p>

Wachstumsst\u00f6rungen unter Therapie mit Methylphenidat?<\/em><\/strong><\/span><\/p>

[Apotheker Benedikt Stegmann, Prof. Dr. med. Dr. rer. nat. Ekkehard Haen, Dr. med. Marina Hiltl]<\/span>
<\/span><\/p>

NeuroTransmitter 2013; 24 (7-8): 33-35<\/span>
Copyright: \u00a9 Urban & Vogel (2013) – neurotrans7\/82013.pdf [619 KB]<\/span><\/p>

 <\/p>

COMT-Polymorphismus und GST-Mangel<\/strong><\/em><\/span><\/p>

[cand. rer. nat. Monika Baier, Dr. med. Peter Lauer, Prof. Dr. med. Dr. rer nat. Ekkehard Haen]<\/span><\/p>

NeuroTransmitter 2013; 24 (4): 49-52<\/span>
Copyright: \u00a9 Urban & Vogel (2013) – neurotrans42013.pdf [560 KB]<\/span><\/p>

 <\/p>

<\/span><\/p>

Welches Diuretikum bei Lithiumtherapie?<\/strong><\/em><\/span><\/p>

[cand. rer. nat. Julia Ortlieb, cand. rer. nat. Monika Baier, Dr. med. Josefine R\u00f6der-Aigner, Prof. Dr. med. Bruno Oerlinghausen, Prof. Dr. med. Dr. rer nat. Ekkehard Haen]<\/span><\/p>

NeuroTransmitter 2013; 24 (2): 45-47<\/span>
Copyright: \u00a9 Urban & Vogel (2013) – neurotrans22013.pdf [277 KB]<\/span><\/p>

<\/span><\/p>

 <\/p>

2012

Kardiovaskul\u00e4res Risiko bei ADHS-Behandlung<\/em> <\/strong><\/span>
[Dr. med. Katharina Wenzel-Seifert, Prof. Dr. med. Dr. rer. nat. Ekkehard Haen]<\/span><\/p>

NeuroTransmitter 10 (2012): Seite 49+50+52<\/span>
Copyright: \u00a9 Urban & Vogel (2012) – neurotrans_10_2012.pdf [244 KB]<\/span><\/p>



Tics bei Kindern und Jugendlichen<\/em> <\/strong><\/span>
[cand. rer. nat. Franziska Menke, Dr. med. Katharina Wenzel-Seifert, Michael Babl, Arzt, Prof. Dr. med. Dr. rer. nat. Ekkehard Haen]<\/span><\/p>

NeuroTransmitter 7 (2012): Seite 43-45<\/span>
Copyright: \u00a9 Urban & Vogel (2012) – neurotrans_7_2012.pdf [238 KB]<\/span>
<\/span><\/p>

 <\/p>

Rote Hand Briefe Citalopram Escitalopram?<\/em> <\/strong><\/span>
[Dr. med. Katharina Wenzel-Seifert, Prof. Dr. med. Dr. rer. nat. Ekkehard Haen]<\/span><\/p>

PPT 19. Jahrgang Heft 1 (2012): Seite 25-30<\/span>
Copyright: \u00a9 Wissenschaftliche Verlagsgesellschaft Stuttgart (2012) – ppt-1-12_haen_rote-hand-briefe_1.pdf [207 KB]<\/span><\/p>

<\/span><\/p>


2011<\/strong><\/span>

Risikoprofil bei SSRI am g\u00fcnstigsten?<\/em> <\/strong><\/span>
[cand. rer. nat. Roland Mendl, Dr. med. Annemarie Lenner, Prof. Dr. med. Dr. rer. nat. Ekkehard Haen]<\/span><\/p>

NeuroTransmitter 9 (2011): Seite 38+41<\/span>
Copyright: \u00a9 Urban & Vogel (2011) – neurotrans_9_2011.pdf [865 KB]<\/span><\/p>

<\/span><\/p>

Suizid durch Rizinsamen?<\/em> <\/strong><\/span>
[cand. rer. nat. Andrea Lamecker, Prof. Dr. med. Dr. rer. nat. Ekkehard Haen]<\/span><\/p>

NeuroTransmitter 6 (2011): Seite 44+45<\/span>
Copyright: \u00a9 Urban & Vogel (2011) – neurotrans_6_2011.pdf [264 KB]<\/span><\/p>



Asenapin – ein neues Antipsychotikum?<\/strong><\/span><\/em><\/span>
[cand. rer. nat. Katja Tischhauser, Prof. Dr. med. Dr. rer. nat. Ekkehard Haen]<\/span><\/p>

NeuroTransmitter 5 (2011): Seite 50+51<\/span>
Copyright: \u00a9 Urban & Vogel (2011) – neurotrans_5_2011.pdf [565 KB]<\/span>



2010<\/strong><\/span>

Haloperidol nicht mehr intraven\u00f6s?<\/strong><\/span><\/em><\/span>
[cand. rer. nat. Laura Hiesinger, Dr. med. Markus Wittmann, Wolfgang Schreiber, Prof. Dr. med. Dr. rer. nat. Ekkehard Haen]<\/span>
<\/span><\/p>

NeuroTransmitter 9 (2010): Seite 22+23<\/span>
Copyright: \u00a9 Urban & Vogel (2010) – neurotrans92010.pdf [114 KB]<\/span><\/p>



Fibromyalgie und GST-Defekt – \u00dcberlegungen zu therapeutischen Alternativen<\/strong><\/span><\/em><\/span>
[cand. rer. nat. Jan Zaloga, Prof. Dr. med. Dr. rer. nat. Ekkehard Haen]<\/span><\/p>

NeuroTransmitter 3 (2010): Seite 34+37<\/span>
Copyright: \u00a9 Urban & Vogel (2010) – neurotrans32010.pdf [377 KB]<\/span><\/p>

 <\/p>


2009<\/strong><\/span>

Neues DepotneuroleptikumZypadhera – Prek\u00e4res Postinjektionssyndrom<\/strong><\/span><\/em><\/span>
[Michael Hicks, Dr. med. Katharina Wenzel-Seifert, Prof. Dr. med. Dr. rer. nat. Ekkehard Haen, NeuroTransmitter 10 (2009): Seite 46+48]<\/span>
Copyright: \u00a9 Urban & Vogel (2009) – neurotrans102009.pdf [233 KB]<\/span><\/p>


Dunkle Materie der Pharmakovigilanz<\/strong><\/span><\/em><\/span>
[Dr. med. Markus Wittmann, Prof. Dr. med. Dr. rer. nat. Ekkehard Haen, NeuroTransmitter 7\/8 (2009): Seite 39+40]<\/span>
Copyright: \u00a9 Urban & Vogel (2009) – neurotrans7\/82009.pdf [76 KB]<\/span><\/p>

 <\/p>


2008<\/strong><\/span><\/p>


Warum Citalopram nicht mit Pimozid kombinieren?<\/strong><\/span><\/em><\/span>
[A. Gail, Prof. Dr. med. Dr. rer. nat. Ekkehard Haen, NeuroTransmitter 11 (2008): Seite 55]<\/span>
Copyright: \u00a9 Urban & Vogel (2008) – neurotrans112008.pdf [64 KB]<\/span><\/p>


Kognitive Beeintr\u00e4chtigung unter Lamotrigin?<\/strong><\/span><\/em><\/span>
[Nora Pfister, <\/strong>Apothekerin Christine Greiner, Prof. Dr. med. Dr. rer. nat. Ekkehard Haen, NeuroTransmitter 10 (2008): Seite 68+71]<\/span>
Copyright: \u00a9 Urban & Vogel (2008) – neurotrans102008.pdf [142 KB]<\/span>

 Mit Omega-3-Fetts\u00e4uren gegen ADHS?<\/strong><\/span><\/em><\/span>
[Apothekerin Christine Greiner, Prof. Dr. med. Dr. rer. nat. Ekkehard Haen, NeuroTransmitter 4 (2008): Seite 68+71]<\/span>
Copyright: \u00a9 Urban & Vogel (2008) – neurotrans42008.pdf [116 KB]<\/span>

Triptane und Antidepressiva – eine Risikoabsch\u00e4tzung?<\/strong><\/span><\/em><\/span>
[Apothekerin Astrid Hader, Dr. Thomas Stammschulte, Prof. Dr. med. Dr. rer. nat. Ekkehard Haen, NeuroTransmitter 3 (2008): Seite 66+68]<\/span>
Copyright: \u00a9 Urban & Vogel (2008) – neurotrans32008.pdf [99 KB]<\/span>


2006<\/strong><\/span>

Appell an Vernunft und Verantwortung bei Clozapin-Verordnung!<\/strong><\/span><\/em><\/span>
[Prof. Dr. med. Dr. rer. nat. Ekkehard Haen, NeuroTransmitter 2 (2006): Seite 78]<\/span>
Copyright: \u00a9 Urban & Vogel (2006) – neurotrans22006.pdf [77 KB]<\/span>

Wie sicher sind Arzneimittel?<\/strong><\/span><\/em><\/span>
[Prof. Dr. med. Dr. rer. nat. Ekkehard Haen, NeuroTransmitter 6 (2006): Seite 73]<\/span>
Copyright: \u00a9 Urban & Vogel (2006) – neurotrans62006.pdf [105 KB]<\/span>

SSRI: Riskant bei Brustkrebs?<\/strong><\/span><\/em><\/span>
[cand. rer. nat. Stefanie Heinz, PD Dr. med. Franz Worek, Prof. Dr. med. Dr. rer. nat. Ekkehard Haen, NeuroTransmitter 11 (2006): Seite 69]<\/span>
Copyright: \u00a9 Urban & Vogel (2006) – neurotrans112006.pdf [102 KB]<\/span>


2005<\/strong><\/span>

Depression bei Isotretinoin-Therapie<\/strong><\/span><\/em><\/span>
[Dr. med. Franz Worek, Prof. Dr. med. Dr. rer. nat. Ekkehard Haen, NeuroTransmitter 1 (2005): Seite 65]<\/span>
Copyright: \u00a9 Urban & Vogel (2005) – neurotrans12005.pdf [60 KB]<\/span><\/p>


Vorsicht mit Neuroleptika bei \u00e4lteren Patienten!<\/strong><\/span><\/em><\/span>
[Prof. Dr. med. Dr. rer. nat. Ekkehard Haen, Dr. med. David Fischer-Barnicol, NeuroTransmitter 5 (2005): Seite 66]<\/span>
Copyright: \u00a9 Urban & Vogel (2005) – neurotrans52005.pdf [73 KB]<\/span>


2004<\/strong><\/span>

Psychose unter Voriconazol<\/strong><\/span><\/em><\/span>
[Dr. med. Christine Goepfert, Prof. Dr. med. Dr. rer. nat. Ekkehard Haen, NeuroTransmitter 10 (2004): Seite 69-70]<\/span>
Copyright: \u00a9 Urban & Vogel (2004) – neurotrans1022004.pdf [121 KB]<\/span>

Off-label-use bei Parkinson-Psychose<\/strong><\/span><\/em><\/span>
[Prof. Dr. med. Dr. rer. nat. Ekkehard Haen, Dr. med. Birgit M\u00f6\u00dfner-Haug, NeuroTransmitter 10 (2004): Seite 68]<\/span>
Copyright: \u00a9 Urban & Vogel (2004) – neurotrans1012004.pdf [75 KB]<\/span>

Linezolid \u2013 ein Antibiotikum mit Bedeutung f\u00fcr die Psychiatrie?<\/strong><\/span><\/em><\/span>
[Dr. med. Christine Goepfert, Prof. Dr. med. Dr. rer. nat. Ekkehard Haen, NeuroTransmitter 9 (2004): Seite 68-69]<\/span>
Copyright: \u00a9 Urban & Vogel (2004) – neurotrans92004.pdf [80 KB]<\/span>

Stellungnahme zu \u201eRote Hand Briefen\u201c – Anwendung von Olanzapin (Zyprexa\u00ae) und Risperidon (Risperdal\u00ae) bei \u00e4lteren Patienten<\/strong><\/span><\/em><\/span>
[cand. rer. nat. Miriam Steur, Prof. Dr. med. Dr. rer. nat. Ekkehard Haen, NeuroTransmitter 7\/8 (2004): Seite 44]<\/span>
Copyright: \u00a9 Urban & Vogel (2004) – neurotrans782004_2.pdf [45 KB]<\/span><\/p>

 <\/p>\n

2004 1 AID Rote Hand Briefe zu Olanzapin und Risperidon im Alter<\/a>Download<\/a><\/div>\n\n\n\n
2004 2 AID Linezolid<\/a>Download<\/a><\/div>\n\n\n\n
2004 3 AID „off-label use“ bei Parkinson Psychose<\/a>Download<\/a><\/div>\n\n\n\n
2004 4 AID Voriconazol<\/a>Download<\/a><\/div>\n\n\n\n
2005 1 AID Vorsicht mit Neuroleptika bei \u00e4lteren Menschen<\/a>Download<\/a><\/div>\n\n\n\n
2005 2 AID Depression bei Isotretinoin Therapie<\/a>Download<\/a><\/div>\n\n\n\n
2006 1 AID Apell an Vernunft und Verantwortung bei Clozapin Vereordnung<\/a>Download<\/a><\/div>\n\n\n\n
2006 2 AID Wie sicher sind Medikamente<\/a>Download<\/a><\/div>\n\n\n\n
2006 3 AID SSRI Riskant bei Brustkrebs?<\/a>Download<\/a><\/div>\n\n\n\n
2008 1 AID Triptane und Antidepressiva – Eine Risikoabsch\u00e4tzung<\/a>Download<\/a><\/div>\n\n\n\n
2008 2 AID Mit Omega-3-Fetts\u00e4uren gegen ADHS?<\/a>Download<\/a><\/div>\n\n\n\n
2008 3 AID Kognitive Beeintr\u00e4chtigungen unter Lamotrigin?<\/a>Download<\/a><\/div>\n\n\n\n
2008 4 AID Warum Citalopram nicht mit Pimozid kombinieren?<\/a>Download<\/a><\/div>\n\n\n\n
2009 1 AID Dunkle Materie der Pharmakovigilanz<\/a>Download<\/a><\/div>\n\n\n\n
2009 2 AID Zypadhera: Prek\u00e4res Postinjektionssyndrom<\/a>Download<\/a><\/div>\n\n\n\n
2010 1 AID Fibromyalgie und GST-Defekt<\/a>Download<\/a><\/div>\n\n\n\n
2010 2 AID Haloperidol nicht mehr intraven\u00f6s<\/a>Download<\/a><\/div>\n\n\n\n
2011 1 AID Asenapin – ein neues Antipsychotikum<\/a>Download<\/a><\/div>\n\n\n\n
2011 2 AID Suizid durch Rizinsamen<\/a>Download<\/a><\/div>\n\n\n\n
2011 3 AID Antidepressive Therapie bei Glaukom<\/a>Download<\/a><\/div>\n\n\n\n
2012 1 AID Rote-Hand-Briefe Citalopram<\/a>Download<\/a><\/div>\n\n\n\n
2012 2 AID TICS bei Kindern und Jugendlichen<\/a>Download<\/a><\/div>\n\n\n\n
2012 3 AID Kardiovaskul\u00e4res Risiko bei ADHS<\/a>Download<\/a><\/div>\n\n\n\n
2013 1 AID Welches Diuretikum bei Lithiumtherapie?<\/a>Download<\/a><\/div>\n\n\n\n
2013 2 AID COMT Polymorphismus und GST Mangel<\/a>Download<\/a><\/div>\n\n\n\n
2013 3 AID Wachstumsst\u00f6rungen unter Therapie mit Methylphenidat<\/a>Download<\/a><\/div>\n\n\n\n
2013 4 AID Tianeptin – ein neues Antidepressivum?<\/a>Download<\/a><\/div>\n\n\n\n
2013 4 AID Tianeptin – ein neues Antidepressivum? Literatur<\/a>Download<\/a><\/div>\n\n\n\n
2015 1 AID Lisdexamfetamindimesilat bei ADHS<\/a>Download<\/a><\/div>\n\n\n\n
2013 5 AID Loxapin – ein neues Antipsychotikum?<\/a>Download<\/a><\/div>\n\n\n\n
2015 2 AID Vortioxetin – ein neues Antidepressivum<\/a>Download<\/a><\/div>\n\n\n\n
2015 3 AID Stellenwert von ADSPro\u00ae bei ADHS<\/a>Download<\/a><\/div>\n\n\n\n
2016 2 AID Allesk\u00f6nner Vitamin D<\/a>Download<\/a><\/div>\n\n\n\n
2016 1 AID Therapiealternative mit einem neuen Depotantipsychotikum<\/a>Download<\/a><\/div>\n\n\n\n
2016 3 AID Knochenbr\u00fcche durch Opipramol?<\/a>Download<\/a><\/div>\n\n\n\n
2016 4 AID Trevicta<\/a>Download<\/a><\/div>\n\n\n\n
2016 5 AID Guanfacin – Vom Blutdrucksenker zum Mittel der Wahl bei ADHS?<\/a>Download<\/a><\/div>\n\n\n","protected":false},"excerpt":{"rendered":"

  Stellungnahmen der AGATE {attachments}  2018 AID Gentests [Copyright\u00a9 cand. rer. nat.Matthias Sicklinger, Dr. rer. nat. Bianca Fay, Ap. Katharina Endres, Ap. Florian Ridders, Prof. Dr. med. Dr. rer. nat. Ekkehard Haen mit Diskussionbeitr\u00e4gen von Br\u00e4utigam K (Berlin), Hillemacher (N\u00fcrnberg), Hoffmann K (Reichenau), Holter P (Regensburg), Kiefl J (Weiden), Kirchmeier T (Bischofsgr\u00fcn), Knorr R (Reichenau), […]<\/p>\n","protected":false},"author":3,"featured_media":0,"parent":73,"menu_order":87,"comment_status":"closed","ping_status":"closed","template":"","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"_mc_calendar":[],"footnotes":""},"class_list":["post-25","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.amuep-agate.de\/cms\/wp-json\/wp\/v2\/pages\/25","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.amuep-agate.de\/cms\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.amuep-agate.de\/cms\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.amuep-agate.de\/cms\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.amuep-agate.de\/cms\/wp-json\/wp\/v2\/comments?post=25"}],"version-history":[{"count":2,"href":"https:\/\/www.amuep-agate.de\/cms\/wp-json\/wp\/v2\/pages\/25\/revisions"}],"predecessor-version":[{"id":646,"href":"https:\/\/www.amuep-agate.de\/cms\/wp-json\/wp\/v2\/pages\/25\/revisions\/646"}],"up":[{"embeddable":true,"href":"https:\/\/www.amuep-agate.de\/cms\/wp-json\/wp\/v2\/pages\/73"}],"wp:attachment":[{"href":"https:\/\/www.amuep-agate.de\/cms\/wp-json\/wp\/v2\/media?parent=25"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}